{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:19:06Z","timestamp":1792793946655,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejmech.2022.114630","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T22:55:28Z","timestamp":1660172128000},"page":"114630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator"],"prefix":"10.1016","volume":"242","author":[{"given":"Jie","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai-Sai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114630_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.114630_bib2","doi-asserted-by":"crossref","first-page":"P837","DOI":"10.1016\/j.jalz.2015.06.1858","article-title":"P4-151: World Alzheimer report 2014: dementia and risk reduction","volume":"11","author":"Wortmann","year":"2015","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ejmech.2022.114630_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111880","article-title":"Novel anti-Alzheimer phenol-lipoyl hybrids: synthesis, physicochemical characterization, and biological evaluation","volume":"186","author":"Pagoni","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib4","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1021\/acs.jmedchem.0c00352","article-title":"Matrix metalloproteinases as new targets in Alzheimer's disease: opportunities and challenges","volume":"63","author":"Zipfel","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.neubiorev.2011.03.001","article-title":"Revisiting the cholinergic hypothesis in the development of Alzheimer's disease","volume":"35","author":"Craig","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2022.114630_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer's disease and its treatment by different approaches: a review","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113224","article-title":"Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer\u2019s action: design, synthesis, crystal structure and in-vitro biological evaluation","volume":"215","author":"Manzoor","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","article-title":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease","volume":"151","author":"Ismaili","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2022.114630_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114630_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114630_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.sjbs.2014.05.003","article-title":"Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms","volume":"22","author":"Mushtaq","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ejmech.2022.114630_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2020.100054","article-title":"Serum levels of resistin and its relationship with some pro-inflammatory cytokines in a cohort of Egyptian patients with Alzheimer's disease","volume":"1","author":"Azzam","year":"2020","journal-title":"Endocr. Metab. Sci."},{"key":"10.1016\/j.ejmech.2022.114630_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120111","article-title":"Nrf2\/Keap1\/ARE signaling: towards specific regulation","volume":"291","author":"Ulasov","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2022.114630_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2020.06.028","article-title":"Transcription factor NRF2 as a promising therapeutic target for Alzheimer's disease","volume":"159","author":"Qu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2022.114630_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113441","article-title":"Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease","volume":"219","author":"Qu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.intimp.2013.06.032","article-title":"Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying\/antioxidant enzymes in microglia","volume":"17","author":"Park","year":"2013","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2022.114630_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2021.102151","article-title":"Benincasa hispida alleviates amyloid pathology by inhibition of Keap1\/Nrf2-axis: emphasis on oxidative and inflammatory stress involved in Alzheimer's disease model","volume":"88","author":"Rapaka","year":"2021","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejmech.2022.114630_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114044","article-title":"Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116742","article-title":"Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease","volume":"61","author":"Kumar","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib21","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib22","series-title":"Dual-acting Compounds Acting as Receptor Ligands and Enzyme Inhibitors, Design of Hybrid Molecules for Drug Development","first-page":"P137","author":"Dolles","year":"2017"},{"key":"10.1016\/j.ejmech.2022.114630_bib23","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1016\/j.bmc.2018.08.019","article-title":"Novel multi-target compounds in the quest for new chemotherapies against Alzheimer's disease: an experimental and theoretical study","volume":"26","author":"Mart\u00ednez","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib24","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/acschemneuro.9b00171","article-title":"Xanthohumol analogues as potent Nrf2 activators against oxidative stress mediated damages of PC12 cells","volume":"10","author":"Bai","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114630_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bmc.2006.09.053","article-title":"Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and Nacetyl-L-cysteine-preparation of S-substituted thiosuccinic acid esters","volume":"15","author":"Schmidt","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib26","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1021\/acs.jmedchem.6b01178","article-title":"The antioxidant additive approach for Alzheimer's disease therapy: new ferulic (Lipoic) acid plus melatonin modified Tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (erythroid-derived 2)-like 2 activators","volume":"59","author":"Benchekroun","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2022.114630_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2022.114630_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cts.12606","article-title":"Tranilast treatment attenuates cerebral ischemia-reperfusion injury in rats through the inhibition of inflammatory responses mediated by NF-kB and PPARs","volume":"12","author":"Zhuo","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ejmech.2022.114630_bib30","first-page":"12","article-title":"Antimicrobial properties of metal piperidine dithiocarbamate complexes against Staphylococcus aureus and Candida albicans","volume":"1","author":"Boadi","year":"2021","journal-title":"Scientific African"},{"key":"10.1016\/j.ejmech.2022.114630_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113801","article-title":"Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers","volume":"225","author":"Song","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib32","article-title":"Synthesis and screening of thiosemicarbazide-dithiocarbamate conjugates for antioxidant and anticancer activities","volume":"124","author":"Narkhede","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103027","article-title":"Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with \u03b2-amyloid anti-aggregation properties for the treatment of Alzheimer's disease","volume":"89","author":"Jiang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejmech.2018.01.055","article-title":"Design, synthesis and biological evaluation of new coumarindithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"146","author":"Jiang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114630_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bioorg.2018.10.056","article-title":"Novel tacrine-coumarin hybrids linked to 1,2,3-triazole as anti-Alzheimer's compounds: in vitro and in vivo biological evaluation and docking study","volume":"83","author":"Najafi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.scijus.2014.06.004","article-title":"Parallel artificial membrane permeability assay for blood-brain permeability determination of illicit drugs and synthetic analogues","volume":"54","author":"Clemons","year":"2014","journal-title":"Sci. Justice"},{"key":"10.1016\/j.ejmech.2022.114630_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111687","article-title":"Recent advances in \u03b1,\u03b2-unsaturated carbonyl compounds as mitochondrial toxins","volume":"183","author":"Hossain","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib40","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1021\/acs.jmedchem.5b00410","article-title":"Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents","volume":"58","author":"Peng","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib41","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/jf505075n","article-title":"Xanthohumol, a polyphenol chalcone present in hops, activating Nrf2 enzymes to confer protection against oxidative damage in PC12 Cells","volume":"63","author":"Yao","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib42","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/acschemneuro.0c00713","article-title":"Ginnalin A binds to the subpockets of keap1 kelch domain to activate the Nrf2-regulated antioxidant defense system in SH-SY5Y cells","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114630_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174829","article-title":"Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups","volume":"919","author":"Zhang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114630_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127780","article-title":"Synthesis of 4-(3-oxo-3-phenylpropyl)morpholin-4-ium chloride analogues and their inhibitory activities of nitric oxide production in lipopolysaccharide-induced BV2 cells","volume":"36","author":"Yoon","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114630_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114463","article-title":"Design, synthesis of novel triptolide-glucose conjugates targeting glucose Transporter-1 and their selective antitumor effect","volume":"238","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib46","volume":"vol. 118","author":"Bay","year":"2021"},{"key":"10.1016\/j.ejmech.2022.114630_bib47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bmc.2015.01.042","article-title":"Design, synthesis and evaluation of chromone-2-carboxamido-alkylbenzylamines as multifunctional agents for the treatment of Alzheimer's disease","volume":"23","author":"Liu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114630_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113154","article-title":"Design, synthesis, and biological evaluation of novel xanthonealkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"213","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:42:01Z","timestamp":1759329721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422005323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":48,"alternative-id":["S0223523422005323"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114630","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114630"}}